| IPO/EPO Reform Details | ||
| Reform ID | B86 | |
| IPO Sr. No. | 4403 | |
| Appendix | B-II | |
| PCT Code | 3006.6 | |
| Commodity Description | ||
| Department | Drug Regulatory Authority of Pakistan - DRAP | |
| Sector | ||
| Start Date | 19-05-2026 | |
| Implementation Date | ||
| CCORR Direction | ||
| Cost Saving | ||
| Progress | 100% | |
| One-liner | Eliminate chemical contraceptive preparations from drug import requirement as they are not medical devices under MDR 2017 | |
| Description | Based on a review of the product contents, chemical contraceptive preparations based on hormones or spermicides do not qualify as medical devices under the Medical Device Rules 2017, so their inclusion under the current drug import requirement is not appropriate. | |
| Import Requirement | ||
| Reason for Omission | As per contents it is perceived that these are not medical devices as per MDR, 2017 | |
| Evidence | ||
Asaan Karobar
Pakistan Regulatory Modernization Initiative
